Study Supporters



Funding for pediatric patients is funded by Children's Healthcare of Atlanta Friends Foundation Research Grant.




Kuvan® for the participants in the BH4-unresponsive group is provided by BioMarin Pharmaceuticals Inc.




This study is also supported in part by PHS Grant UL1 RR025008 from the Clinical and Translational Science Award program, National Institutes of Health, National Center for Research Resources